While there is no clear link between elements of ERBB-signaling and STAT3 during involution, there is evidence from multiple breast cancer lines that ERBB2-ERBB3 heterodimers can activate STAT3 upon NRG binding, in a signaling network that also involves the PR and the ERK1/2 pathway [191]. Here, EGFR is linked to breast carcinoma.